FDA Approved: TIAGABINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for tiagabine hydrochloride under NDA No. NDA020646, managed by Teva Pharmaceuticals USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial Seizures

Drugs mentioned

• Tiagabine hydrochloride (tiagabine hydrochloride)

Snippet

SUPPL AP for TIAGABINE HYDROCHLORIDE (TIAGABINE HYDROCHLORIDE)